We are happy to share the news that a team of researchers from the MD Anderson Cancer Center have come up with a new way to make stem cell transplants more effective in patients with leukemia, lymphoma and other blood cancers and disorders.
As we know, transplanting cord blood instead of bone marrow or peripheral blood has several advantages, among them that the cord blood doesn’t have to be a perfect match for a patient.
With the new method, researchers have manipulated one batch of stem cells in patients to undergo a double transplant. By doing so, they share they have seen “much more consistent, solid [development], and people needed less transfusion.”
Read more by following the link below: